Humira Biosimilars Prepare For US Competition In 2023

Landmark LOE Opportunity Looms, With Multiple Adalimumab Launches Expected

 
• By David Wallace
Starter's Orders
Multiple Humira biosimilars are on the starting blocks awaiting launch in 2023 • Source: Shutterstock

More from Outlook Archive

More from Outlook 2024